Research news

A quicker, cheaper MRI scan is just as accurate at diagnosing prostate cancer as the current 30-40 minute scan and should be rolled out to make MRI scans more accessible to men who need one, according to clinical trial results led by UCLH, UCL and the University of Birmingham.

A new treatment has been shown to significantly lower blood pressure in people whose levels stays dangerously high, despite taking several existing medicines, according to the results of a Phase III clinical trial led supported by the National Institute for Health and Care Research Biomedical Research Centre at UCLH.

A new national registry is helping researchers understand more about inherited hearing loss – and could help bring about new treatments.

UCLH has been selected as the lead site in Great Britain for Neuralink’s GB-PRIME study, a clinical investigation for Neuralink’s brain-computer interface (BCI).

UCLH has recruited the first participant in the UK to a study looking at a new investigational drug for patients with a condition affecting the blood vessels in the brain called cerebral amyloid angiopathy (CAA).